Evaluation of the retinal electrofisiological response in patients with compensated GLAUCOMA POAG in treatment with epigallocatechin-gallate Epinerve . - ND

• Conditions: glaucoma; MedDRA version: 9.1Level: HLGTClassification code 10018307Term: Glaucoma and ocular hypertension

• Registration Number: EUCTR2006-005943-27-IT
• Lead Sponsor: POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2007-01-30
• Last Update Posted: 19 March 2012

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

INCLUSION CRITERIA IN OHT PATIENTS 61623; IOP 21 mm Hg in two separate occasions at diagnosis. 61623; IOP steady at least in the last three months. 61623; Optic nerve head with normal morphology in stereoscopic evaluation performed with biomicroscopy and 78D lens. 61623; Standard automated perimetry Humphrey 30-2 SITA Standard test within normal limits. 61623; Alteration of PERG. 61623; Familiarity for glaucoma INCLUSION CRITERIA IN EOAG PATIENT 61623; IOP 21 mm Hg in two separate occasions at diagnosis. 61623; IOP steady at least in the last three months. 61623; Optic nerve head with normal morphology in stereoscopic evaluation performed with biomicroscopy and 78D lens. 61623; Standard automated perimetry Humphrey 30-2 SITA Standard test out of normal limits.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

61623; Therapy change. 61623; Smokers. 61623; Antecedent ocular surgeries. 61623; Concomitant ocular or systemic diseases.

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified